TERN
NASDAQ · Pharmaceuticals
Terns Pharmaceuticals Inc
$52.95
+0.00 (+0.00%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+0.00%
1Y
+186.68%
YTD
+32.01%
Open$52.95
Previous Close$52.95
Day High$52.95
Day Low$52.95
52W High$53.19
52W Low$12.77
Volume—
Avg Volume2.44M
Market Cap6.12B
P/E Ratio—
EPS$-1.03
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$50.16
Above
SMA 200
$28.69
Above
RSI (14)
81.8
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Hold
17 analysts
Price Target
-29.8% upside
Current
$52.95
$52.95
Target
$37.17
$37.17
$32.00
$37.17 avg
$56.15
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 649.21M | 641.61M | 607.21M |
| Net Income | 208.45M | 199.92M | 172.59M |
| Profit Margin | 32.1% | 31.2% | 28.4% |
| EBITDA | 253.94M | 217.05M | 208.00M |
| Free Cash Flow | 152.21M | 227.98M | 177.76M |
| Rev Growth | -4.4% | +22.1% | +20.7% |
| Debt/Equity | 0.17 | 0.24 | 0.20 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |